ORKA: Oruka Therapeutics, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 17 sales totaling $4.13M in the last 180 days.
Insider sales
| Trade date | Insider | Role | Value | 10b5-1 plan |
|---|---|---|---|---|
| 2026-10-20 | Quinlan Paul T | Officer | $30K | yes |
| 2026-10-20 | Quinlan Paul T | Officer | $38K | yes |
| 2026-10-20 | Quinlan Paul T | Officer | $77K | yes |
| 2026-10-20 | Quinlan Paul T | Officer | $323K | yes |
| 2026-10-20 | Quinlan Paul T | Officer | $238K | yes |
| 2026-10-15 | Goncalves Joana | Officer | $211K | yes |
| 2026-10-15 | Goncalves Joana | Officer | $138K | yes |
| 2026-10-15 | Goncalves Joana | Officer | $106K | yes |
| 2026-10-15 | Goncalves Joana | Officer | $54K | yes |
| 2026-10-15 | Goncalves Joana | Officer | $16K | yes |
| 2026-10-12 | Agarwal Arjun | President | $459K | yes |
| 2026-10-12 | Agarwal Arjun | President | $170K | yes |
| 2026-10-12 | Agarwal Arjun | President | $160K | yes |
| 2026-10-12 | Agarwal Arjun | President | $17K | yes |
| 2026-10-01 | Klein Lawrence Otto | CEO | $1.35M | yes |
| 2026-10-01 | Klein Lawrence Otto | CEO | $719K | yes |
| 2026-10-01 | Klein Lawrence Otto | CEO | $17K | yes |
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | 13G amendment | Venrock Healthcare Capital Partners III, L.P. | 7.40% | SEC | |
| 2026-08-14 | Fell below 5% | VIKING GLOBAL INVESTORS LP | 2.50% | SEC | |
| 2026-08-14 | New 13G stake | RTW Investments, LP | 5.20% | SEC | |
| 2026-08-12 | New 13G stake | Capital World Investors | 5.60% | SEC |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.